相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-beta/SMAD/MAPK signaling pathways
Maha G. Elfeky et al.
LIFE SCIENCES (2020)
Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo
Gauthami Pulivendala et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Cryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway
Ying-Hua He et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells
Eun-Ryeong Hahm et al.
CELL CYCLE (2016)
Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis
Ilknur Bingul et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2016)
Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress
Ji Hye Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
MicroRNA134 Mediated Upregulation of JNK and Downregulation of NFkB Signalings Are Critically Involved in Dieckol Induced Antihepatic Fibrosis
Sang Yoon Lee et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Quercetin stimulates mitochondrial apoptosis dependent on activation of endoplasmic reticulum stress in hepatic stellate cells
Liwei He et al.
PHARMACEUTICAL BIOLOGY (2016)
Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Ting Liu et al.
MEDIATORS OF INFLAMMATION (2015)
Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection
Chih-Yeu Fang et al.
VIRUSES-BASEL (2015)
Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling
Yinfeng Dong et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction
Chih-Jung Yao et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling
Tripti Singh et al.
PLOS ONE (2013)
Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity
Vemula Praveen Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Wnt/beta-Catenin Signaling: a Promising New Target for Fibrosis Diseases
Y. Guo et al.
PHYSIOLOGICAL RESEARCH (2012)
Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA
Chao Zhao et al.
BIOCHIMIE (2011)
Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro
Chih-Kang Chiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
GSK3: a multifaceted kinase in Wnt signaling
Dianqing Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Honokiol protects against carbon tetrachloride induced liver damage in the rat
AH Cao et al.
PHYTOTHERAPY RESEARCH (2005)
Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin
H Hu et al.
ACTA PHARMACOLOGICA SINICA (2005)
Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro
EJ Park et al.
PLANTA MEDICA (2005)
Hepatic stellate cells as a target for the treatment of liver fibrosis
R Bataller et al.
SEMINARS IN LIVER DISEASE (2001)
分享论文
